Nereyal has completed CoPulse, a heart disease digital twin project integrating user-specific data for heart health monitoring and risk assessment.
CoPulse has evolved to analyze heart rate trends autonomously, enabling real-time notifications for irregularities without manual user input.
Upgrades to CoPulse include an asynchronous request-handling system, scheduled jobs to retrieve heart rate data, and a redesigned user interface for better usability.
Future plans for CoPulse involve refining the system, adding anomaly detection, and exploring FDA compliance pathways to make it a real-world product, emphasizing the importance of using technology for meaningful solutions.